| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2849379 | American Heart Journal | 2014 | 11 Pages |
Abstract
All-comer AMI patients undergoing percutaneous coronary intervention who received spironolactone had a lower risk of repeat revascularization. Randomized trials are needed.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Pil Sang MD, Dong-Kie MD, Guang-Won MD, Ki-Hun MD, Sang-Hoon MD, PhD, Jeong Hoon MD, Joo-Yong MD, PhD, Seung-Hyuk MD, PhD, Jin-Ho MD, PhD, Hyeon-Cheol MD, PhD, Youngkeun MD, PhD, Myung Ho MD, PhD, Young Bin MD, PhD, Doo-Il MD, PhD,